McCormick reported third-quarter 2026 constant-currency sales growth of 17%, adjusted EPS of $0.86 and gross margin expansion of 180 basis points. Full-year gross margin expansion is expected at the high end of 100 to 120 basis points.
MKC · Mccormick & Co Inc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
McCormick entered a March 31, 2026 merger agreement with Unilever, under which current Unilever shareholders would own approximately 55.1% of the combined company. Third-quarter 2026 net sales rose 17.4%, while diluted earnings per share fell to $0.36 from $0.84.
McCormick reported third-quarter net sales growth of 17.4% and organic growth of 1.9%; adjusted EPS was $0.86 versus $0.85. It reaffirmed fiscal 2026 outlook and said Unilever Foods integration planning remained on track.
On September 24, 2026, McCormick & Company, Incorporated dismissed Ernst & Young LLP because it is not expected to be independent after the anticipated Unilever PLC transaction. The Audit Committee approved KPMG LLP as independent auditor, effective upon EY’s dismissal.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q3 FY26 earnings call · Oct 1, 2026TL;DR. McCormick delivered 17% constant-currency Q3 sales growth on McCormick de Mexico accretion and 2% organic growth, expanded adjusted gross margin by 180bps, but reaffirmed FY26 organic sales growth to the lower end of guidance and the midpoint for adjusted operating income/EPS amid higher input/freight inflation and softer U.S. consumer volumes.
- + Q3 net sales grew 17.4% with 2% organic growth and McCormick de Mexico accretion
- + Adjusted gross margin expanded 180bps in Q3
- + FY26 gross margin expansion now expected at the high end of 100-120bps range
- + Unilever Foods integration is progressing on track with regulatory filings submitted
- + Year-to-date operating cash flow up to ~$600M from $420M prior year
- − FY26 organic sales growth guided to between low-end and midpoint, with ~30bps drag from a Q4 packaging supply constraint
- − FY26 cost inflation raised to 6%-7% from prior mid-single-digit expectation
- − Q4 implied year-over-year gross margin compression expected
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted earnings per share – diluted non-GAAP | $2.32 | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Adjusted gross profit non-GAAP | $2.3B | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Adjusted gross profit margin non-GAAP | 39.4% | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Adjusted income tax expense non-GAAP | $192.8M | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Adjusted income tax rate non-GAAP | 23.5% | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Adjusted net income non-GAAP | $624.5M | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Adjusted operating income non-GAAP | $962.5M | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Adjusted operating income margin non-GAAP | 16.5% | Nine Months Ended 8/31/2026 | — |
|
|
|||
| Segment operating income | $119.5M | the three months ended May 31, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MKC
this stock
Mccormick & Co Inc
|
$12.64B | -31.1% | +1.7% | 8.5 | 6.8% |
|
JBS
Jbs N.V.
|
$40.00B | -15.7% | — | — | 1.3% |
|
KHC
Kraft Heinz Co
|
$29.73B | +3.5% | -0.1% | — | 8.7% |
|
GIS
General Mills Inc
|
$18.35B | -26.2% | +4.1% | — | 7.0% |
|
SJM
J M SMUCKER Co
|
$14.17B | +35.7% | +3.7% | — | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 1, 2026
- This year
- 27
McCormick reported third-quarter net sales growth of 17.4% and organic growth of 1.9%; adjusted EPS was $0.86 versus $0.85. It reaffirmed fiscal 2026 outlook and said Unilever Foods integration planning remained on track.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MKC | -3.0% | +1.3% | +0.3% | -0.7% | -31.1% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -5.6% | +2.5% | -0.2% | -0.5% | -41.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.